Association of germline variation with the survival of women with
Breast cancer
Cancer genetics
Genome-wide association studies
Journal
NPJ breast cancer
ISSN: 2374-4677
Titre abrégé: NPJ Breast Cancer
Pays: United States
ID NLM: 101674891
Informations de publication
Date de publication:
2020
2020
Historique:
received:
21
01
2020
accepted:
11
08
2020
entrez:
23
9
2020
pubmed:
24
9
2020
medline:
24
9
2020
Statut:
epublish
Résumé
Germline genetic variation has been suggested to influence the survival of breast cancer patients independently of tumor pathology. We have studied survival associations of genetic variants in two etiologically unique groups of breast cancer patients, the carriers of germline pathogenic variants in
Identifiants
pubmed: 32964118
doi: 10.1038/s41523-020-00185-6
pii: 185
pmc: PMC7483417
doi:
Types de publication
Journal Article
Langues
eng
Pagination
44Subventions
Organisme : Cancer Research UK
ID : 11174
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : HHSN268201200008C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201200008I
Pays : United States
Organisme : NCI NIH HHS
ID : U19 CA148065
Pays : United States
Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsH.N. has received an honorarium from AstraZeneca. The other authors declare no competing interests.
Références
Nat Genet. 2017 Dec;49(12):1767-1778
pubmed: 29058716
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):126-135
pubmed: 27697780
Nature. 2017 Jan 26;541(7638):541-545
pubmed: 28068668
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Breast. 2017 Feb;31:46-50
pubmed: 27810699
Neoplasia. 2013 Jun;15(6):600-8
pubmed: 23730208
Cancer Cell Int. 2016 Aug 05;16:64
pubmed: 27499703
Mol Cell. 2013 Nov 7;52(3):459-67
pubmed: 24140421
Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47
pubmed: 22144499
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
Neoplasma. 2018 Nov 15;65(6):888-897
pubmed: 30334447
Breast Cancer Res. 2015 Apr 22;17:58
pubmed: 25897948
Mol Cell. 2012 Nov 30;48(4):572-86
pubmed: 23063525
Database (Oxford). 2017 Jan 1;2017:
pubmed: 28605766
Int J Cancer. 2012 May 1;130(9):2103-10
pubmed: 21630259
Am J Pathol. 2001 Jul;159(1):119-30
pubmed: 11438460
Curr Protoc Bioinformatics. 2016 Jun 20;54:1.30.1-1.30.33
pubmed: 27322403
Ann Oncol. 2015 Aug;26(8):1533-46
pubmed: 25939896
Cell Rep. 2018 Apr 17;23(3):823-837
pubmed: 29669287
Nat Genet. 2013 Oct;45(10):1238-1243
pubmed: 24013639
Acta Biochim Biophys Sin (Shanghai). 2017 Jul 1;49(7):581-587
pubmed: 28475688
Medicine (Baltimore). 2016 Oct;95(40):e4975
pubmed: 27749552
Cell. 2014 Dec 18;159(7):1665-80
pubmed: 25497547
J Mol Cell Biol. 2019 Sep 19;11(9):725-735
pubmed: 30590706
Cancers (Basel). 2019 May 28;11(6):
pubmed: 31141992
Breast Cancer Res. 2005;7(4):R465-9
pubmed: 15987451
Virchows Arch. 2018 May;472(5):697-703
pubmed: 29380126
Ann Oncol. 2013 Sep;24(9):2206-23
pubmed: 23917950
Oncotarget. 2017 Jun 27;8(37):61890-61900
pubmed: 28977912
Cancer Res. 2018 Sep 1;78(17):4915-4928
pubmed: 29945962
Ann Oncol. 2012 Dec;23(12):3051-3057
pubmed: 22767585
Onco Targets Ther. 2017 Oct 26;10:5195-5208
pubmed: 29138572
J Neurosci Res. 2010 Dec;88(16):3578-87
pubmed: 20890993
Stem Cells. 2015 Aug;33(8):2442-55
pubmed: 25944056
Cancer Res. 2004 Dec 1;64(23):8541-9
pubmed: 15574760
Int J Cancer. 2013 May 1;132(9):2044-55
pubmed: 23034890
Mol Pathol. 2001 Oct;54(5):300-6
pubmed: 11577171
Oncotarget. 2016 Oct 25;7(43):70699-70714
pubmed: 27683111
Breast Cancer Res Treat. 2010 Oct;123(3):725-31
pubmed: 20020197
PLoS One. 2013 Jul 31;8(7):e70680
pubmed: 23936237
Genome Biol. 2018 Oct 4;19(1):151
pubmed: 30286773
Endocr Rev. 2020 Apr 1;41(2):
pubmed: 31512725
Bioinformatics. 2018 Mar 1;34(5):887-889
pubmed: 28968746
Nat Genet. 2008 Jul;40(7):844-53
pubmed: 18511948
J Clin Oncol. 2009 Mar 10;27(8):1160-7
pubmed: 19204204
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
PLoS One. 2015 Mar 27;10(3):e0120189
pubmed: 25816289
BMC Med Genomics. 2015 Aug 22;8:54
pubmed: 26297356
Ann Oncol. 2019 Jul 1;30(7):1071-1079
pubmed: 31090900
Clin Cancer Res. 2015 Sep 15;21(18):4086-4096
pubmed: 25964295
Cancer Sci. 2017 Dec;108(12):2454-2461
pubmed: 28985022
Br J Cancer. 2019 Mar;120(6):647-657
pubmed: 30787463
Am J Hum Genet. 2007 Aug;81(2):208-27
pubmed: 17668372
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Int J Oncol. 2018 Jul;53(1):167-176
pubmed: 29658564
Int J Biol Sci. 2012;8(1):59-65
pubmed: 22211105
Histopathology. 1991 Nov;19(5):403-10
pubmed: 1757079
N Engl J Med. 2017 Aug 10;377(6):523-533
pubmed: 28578601
Cancer Treat Rev. 2016 Jul;48:34-41
pubmed: 27343437
Clin Cancer Res. 2009 May 1;15(9):3214-22
pubmed: 19383810
Int J Cancer. 2016 Dec 15;139(12):2760-2770
pubmed: 27542569
Mol Cell Biol. 2017 Jun 15;37(13):
pubmed: 28416635
Curr Opin Support Palliat Care. 2014 Mar;8(1):33-8
pubmed: 24270749
Oncotarget. 2015 Apr 10;6(10):7390-407
pubmed: 25823661
Breast Cancer Res. 2007;9(3):R39
pubmed: 17598882
Nature. 2017 Nov 2;551(7678):92-94
pubmed: 29059683
Bioinformatics. 2015 Nov 1;31(21):3555-7
pubmed: 26139635
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Lancet Oncol. 2018 Feb;19(2):169-180
pubmed: 29337092
Lancet Oncol. 2007 Nov;8(11):1001-6
pubmed: 17921068
Dis Mon. 1998 Sep;44(9):421-546
pubmed: 9803240